Literature DB >> 30460286

5-Fluorouracil Loaded Chitosan-PVA/Na+MMT Nanocomposite Films for Drug Release and Antimicrobial Activity.

A Babul Reddy1, B Manjula1, T Jayaramudu1, E R Sadiku1, P Anand Babu2, S Periyar Selvam2.   

Abstract

In the present study, chitosan and polyvinyl alcohol (PVA) were blended with different concentrations of sodium montmorillonite (Na+MMT) clay solution by a solvent casting method. X-ray diffraction and transition electron microscope results show that the film properties are related to the co-existence of Na+MMT intercalation/exfoliation in the blend and the interaction between chitosan-PVA and Na+MMT. 5-Fluorouracil (5-FU) was loaded with chitosan-PVA/Na+MMT nanocomposite films for in vitro drug delivery study. The antimicrobial activity of the chitosan-PVA/Na+MMT films showed significant effect against Salmonella (Gram-negative) and Staphylococcus aureus (Gram-positive), whereas 5-FU encapsulated chitosan-PVA/Na+MMT bio-nanocomposite films did not show any inhibition against bacteria. Our results indicate that combination of a flexible and soft polymeric material with high drug loading ability of a hard inorganic porous material can produce improved control over degradation and drug release. It will be an economically viable method for preparation of advanced drug delivery vehicles and biodegradable implants or scaffolds.

Entities:  

Keywords:  5-Fluorouracil; Antimicrobial activity; Biopolymer; Chitosan–PVA/Na+MMT; Drug release; Montmorillonite

Year:  2016        PMID: 30460286      PMCID: PMC6223683          DOI: 10.1007/s40820-016-0086-4

Source DB:  PubMed          Journal:  Nanomicro Lett        ISSN: 2150-5551


  32 in total

1.  Hepatic arterial 5-fluorouracil in patients with liver metastases of colorectal cancer: single-centre experience in 145 patients.

Authors:  J M van Riel; C J van Groeningen; S H Albers; M Cazemier; S Meijer; R Bleichrodt; F G van den Berg; H M Pinedo; G Giaccone
Journal:  Ann Oncol       Date:  2000-12       Impact factor: 32.976

2.  Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with weekly high-dose 48-hour continuous-infusion fluorouracil for advanced colorectal cancer: a Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD) study.

Authors:  E Aranda; E Díaz-Rubio; A Cervantes; A Antón-Torres; A Carrato; T Massutí; J M Tabernero; J Sastre; A Trés; J Aparicio; J M López-Vega; I Barneto; J García-Conde
Journal:  Ann Oncol       Date:  1998-07       Impact factor: 32.976

3.  A study of purified montmorillonite intercalated with 5-fluorouracil as drug carrier.

Authors:  F H Lin; Y H Lee; C H Jian; Jau-Min Wong; Ming-Jium Shieh; Cheng-Yi Wang
Journal:  Biomaterials       Date:  2002-05       Impact factor: 12.479

4.  Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs.

Authors:  Yuancai Dong; Si-Shen Feng
Journal:  Biomaterials       Date:  2005-10       Impact factor: 12.479

5.  Overcoming 5-Fu resistance in human non-small cell lung cancer cells by the combination of 5-Fu and cisplatin through the inhibition of glucose metabolism.

Authors:  Jun-Gang Zhao; Kai-Ming Ren; Jun Tang
Journal:  Tumour Biol       Date:  2014-09-27

6.  Transport and hydrolysis of urea in a reactor-separator combining an anion-exchange membrane and immobilized urease.

Authors:  D H Chen; J C Leu; T C Huang
Journal:  J Chem Technol Biotechnol       Date:  1994-12       Impact factor: 3.174

7.  A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).

Authors:  S Cascinu; R R Silva; S Barni; R Labianca; L Frontini; E Piazza; G Pancera; P Giordani; L Giuliodori; M A Pessi; V Fusco; G Luporini; R Cellerino; G Catalano
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

8.  Evaluations of biomarkers associated with 5-FU sensitivity for non-small-cell lung cancer patients postoperatively treated with UFT.

Authors:  J Nakano; C Huang; D Liu; D Masuya; T Nakashima; H Yokomise; M Ueno; H Wada; M Fukushima
Journal:  Br J Cancer       Date:  2006-08-01       Impact factor: 7.640

9.  Autophagy inhibition promotes 5-fluorouraci-induced apoptosis by stimulating ROS formation in human non-small cell lung cancer A549 cells.

Authors:  Xiaohong Pan; Xiuli Zhang; Hongliu Sun; Jinjin Zhang; Miaomiao Yan; Huaibin Zhang
Journal:  PLoS One       Date:  2013-02-18       Impact factor: 3.240

Review 10.  Continuous 5-fluorouracil in the treatment of breast cancer.

Authors:  D A Cameron; H Gabra; R C Leonard
Journal:  Br J Cancer       Date:  1994-07       Impact factor: 7.640

View more
  3 in total

1.  Litchi chinensis inspired nanoformulations: a synergy guided approach for unraveling promising cytotoxic attributes of metal and nonmetal conjugates.

Authors:  Amina Hussain; Naila Safdar; Noor-Ul Ain; Rashda Abbasi; Azra Yasmin
Journal:  Toxicol Res (Camb)       Date:  2021-11-28       Impact factor: 3.524

2.  The Synergism of Platinum-Gold Bimetallic Nanoconjugates Enhances 5-Fluorouracil Delivery In Vitro.

Authors:  Vareessh Maney; Moganavelli Singh
Journal:  Pharmaceutics       Date:  2019-09-01       Impact factor: 6.321

3.  Novel linezolid loaded bio-composite films as dressings for effective wound healing: experimental design, development, optimization, and antimicrobial activity.

Authors:  Dina Saeed Ghataty; Reham Ibrahim Amer; Reham Wasfi; Rehab Nabil Shamma
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.